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Abstract
            Autonomic  nervous  system  plays  an  integral  role  in  homeostasis.  Autonomic  modulation  can 
frequently be altered in patients with cardiac disorders as well as in patients with other critical illnesses or 
injuries. Assessment of heart rate variability is based on analysis of consecutive normal R-R intervals and may 
provide  quantitative  information  on  the  modulation  of  cardiac  vagal  and  sympathetic  nerve  input.  The 
hypothesis that depressed heart rate variability may occur over a broad range of illness and injury, and may 
inversely correlated with disease severity and outcome has been tested in various clinical settings over the last 
decade. This article reviews recent literature concerning the potential clinical implications and limitations of 
heart  rate  variability  assessment  in  general  medicine.                           
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           Autonomic nervous system plays an integral role in many aspects of homeostasis, and it is affected by a 
wide  variety  of  pathophysiologic  conditions.  Assessment  of  heart  rate  variability  (HRV) is  based on the 
analysis  of  consecutive  sinus  rhythm R-R  intervals  and  may  provide  quantitative  information  about  the 
modulation of cardiac vagal and sympathetic nerve activities. HRV measurements can be derived from short-
term (2 to 5 minutes) or long-term ECG recordings (24 to 48 hours). It can be quantified in a number of ways 
but techniques of conventional time domain (statistical and geometrical) and frequency domain measurements 
(power spectral density) remain predominantly utilised 1. Recently, analysis of heart rate dynamics by methods 
based on non-linear system theory has been introduced, which may be an alternative way for studying the 
abnormalities  in  heart  rate  behaviour and for  identifying patients  with an increased cardiac mortality  2,3. 
Although HRV has been used as a non-invasive marker of the activity of the autonomic nervous system for 
over two decades, the necessary guidelines have only been established rather recently making comparison 
feasible  between  various  studies1.                           
           Autonomic nervous system plays a central role in the maintenance of hemodynamic stability. Cardiac 
autonomic dysfunction may result in serious complications,  such as malignant cardiac arrhythmias and/or 
sudden cardiac death. The analysis of HRV has been widely explored in cardiac research during last decades. 
HRV  has  been  recognised  as  a  powerful  risk  stratifier  for  adverse  cardiac  events  in  patients  surviving 
myocardial infarction and for identifying patients with diabetic neuropathy. HRV is affected by a number of 
physiological and pathological conditions. Significantly altered HRV can be found not only in cardiac diseases 
but  also  in  a  wide  variety  of  pathophysiologic  disorders  characterised  by  neurohumoral  activation  4.
Physiologic systems constantly change over time and respond to stimuli. Physiologic systems of young healthy 
subjects exhibit marked physiological signal variability and complexity, while aging or diseased systems show 
a loss of variability, decreased complexity, and increased regularity 5. The loss or decreased variability in the 
beat-to-beat intervals has been found in various pathophysiologic disorders 4-9. It has been hypothesised that 
decreased variability of heart rate dynamics may occur over a broad range of critical illness and injury, and 
may be inversely correlated with disease severity and outcome in both adult and paediatric patients. These 
hypotheses have been tested in last decade and have continuously been evaluated in the areas of both cardiac 
and  general  medicine.                                 
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Clinical  application  of  HRV  analysis                                    
            Autonomic  dysfunction  is  frequently  seen  in  cardiac  disorders  or  other  diseases  including  those 
requiring  admission  to  intensive  care  unit  such  as  myocardial  infarction  7,8,  multiple  organ  dysfunction 
syndrome, sepsis  10, and severe head and brain injuries  11. Early studies have clearly showed that HRV is 
significantly depressed and associated with prognosis in post myocardial infarction patients 1. Recently, there 
have been reports suggesting that HRV is significantly altered in patients with critical illness, and associated 
with severity of illness and outcome in patients with head injury or brain death 6,12-18. The phenomenon of 
decomplexification of physiologic dynamics measured by HRV may also have important clinical implications 
in  other  critically  ill  patients  16,19-21.                                         
Cardiovascular  risk  stratification                                              
Myocardial  infarction and angina pectoris                                                           
            A general consensus of a practical use of HRV has been reached in the setting of myocardial infarction. 
Depressed HRV indicates increased risk of malignant arrhythmias and of mortality after acute myocardial 
infarction and the prognostic value of time and geometric parameters of HRV has been consistently confirmed 
1. Carney et al showed by analysis of covariance that HRV index, with the exception of the high-frequency 
components,  remains  significantly  lower  in  patients  with  a  recent  myocardial  infarction  and  depression 
compared to those without depression. This finding may suggest a mechanism linking depression to increased 
cardiac mortality in post infarction patients 7. More recently, a prospective multicentre study showed that 1, a 
fractal  HRV  parameters,  was  the  most  significant  independent  HRV  index  which  predicted  subsequent 
mortality in a multivariate analysis after adjustments for clinical variables and left ventricular ejection fraction 
(relative risk 3.90, 95% CI 2.03 to 7.49, p <0.001) based on 697 survivors of acute myocardial infarction 9. 
Forslund et al. reported that in patients with stable angina pectoris, low HRV predicted cardiovascular death 
but  not  non-fatal  myocardial  infarction  22.                                                  
Congestive  heart  failure                                                             
            A  number  of  recent  studies  confirmed  that  HRV  was  significantly  depressed  in  patients  with 
decompensated heart failure and assessment of HRV could be used to identify heart failure patients with poor 
prognosis 8,23-25. Boveda et al examined the time domain analysis of HRV in 190 patients with heart failure 
and found that depressed HRV was of independent prognostic value 23. A multicentre trial (n=1071) ATRAMI 
demonstrated that HRV, along with baroreflex sensitivity, contributed importantly and additionally to risk 
stratification  in  post-infarction  patients  and  with  left  ventricular  ejection  fraction  <35%  8.  Carvedilol, 
spironolactone and beta-blockers therapy reduced heart rate and improved HRV in congestive heart failure 26-
29. These effects may be attributed to the improvement of autonomic dysfunction 27. Differently, Makikallio et 
al found that HRV indexes, including the standard deviation of RR intervals, HRV index, frequency-domain 
indexes, and the short-term fractal scaling exponent of RR  intervals, failed to provide independent prognostic 
information in patients with the most severe functional impairment 30. More recently, Bilchick et al. reported 
that patients with SDNN <65.3 ms had a significantly increased risk of sudden death (p = 0.016). They showed 
that HRV was the sole independent predictor of overall mortality and was significantly associated with sudden 
death  in  patients  with  ischaemic  cardiomyopathy  24.                                 
Malignant  arrhythmias  and  sudden  cardiac  death                                     
            More  recent  report  from  ATRAMI  confirmed  the  predictive  value  of  HRV  for  life-threatening 
arrhythmias  in  patients  after  myocardial  infarction  8.  HRV  (SDNN,  SDANN)  was  also  found  to  be 
significantly reduced in sudden death survivors of various aetiology 31. Schmitt et al 32 performed a two-step 
risk stratification to identify patients who were at high risk of ventricular arrhythmias after acute myocardial 
infarction,  and used HRV as one of  the non-invasive screening tests  in  1,436 consecutive post-infarction 
patients. A subgroup of 248 patients was identified at high-risk and scheduled for programmed ventricular 
stimulation. During a mean of 607 day follow-up, cardiac mortality was significantly higher in the subgroup of 
96 high-risk patients who declined electrophysiological study (log-rank chi-square 9.38, p = 0.0022, relative 
risk  4.7,  1.6  to  13.9)  compared  to  the  high-risk  group  of  patients  (n=98)  in  whom  a  subsequent  ICD 
implantation  was  guided  by  electrophysiological  testing  32.  In  patients  with  implantable  cardioverter-
defibrillators, Perkiomaki et al found that non-linear measure of HRV (scaling exponent 1) obtained from 
short-term ECG recordings yielded important prognostic information about the risk of appropriate ICD shocks 
and/or  death  33.                            
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Essential  hypertension                                         
            It has been hypothesised that in essential hypertension, an increased sympathetic and reduced vagal 
cardiac drive is coupled with an enhancement of vasomotor sympathetic modulation 34. Essential hypertension 
was associated with impaired cardiac autonomic function 35,36. In a recent study, Mussalo et al showed that the 
severity of essential  hypertension was related to the severity of  impairment of  cardiac autonomic control 
measured by time and frequency domain analysis of HRV  37.                                               
Cardiovascular  surgery                                         
            Both conventional and novel (non-linear) analysis of HRV have been applied to evaluate autonomic 
modulation and cardiovascular function in patients after cardiovascular surgery 38-40. Stein et al 40 examined 
the value of HRV measurements in predicting clinical course in 106 patients undergoing abdominal aortic 
surgery.  24-hour  Holter  recordings  taken  on  postoperative  day  1  were  analysed  for  standard  time  and 
frequency domain indices as well as non-linear slope of HRV. Decreased HRV along with increased age and 
insulin-dependent diabetes were shown to be independent predictors of prolonged hospitalisation (>7 days) 
after the operation. Their findings suggest the potential use of HRV for the prediction of postsurgical resource 
utilisation. HRV analysis was also applied to the assessment of the neural circulatory control after cardiac 
transplantation 39. Altered HRV was associated with myocardial ischaemic episodes in patients after CABG 
41.  Few data  exist  regarding the value  of  preoperative  HRV analysis  for  risk assessment  before vascular 
surgery  42.                                           
Assessment  of  risk  in  neurologic  disorders                                     
Severe  head  injury  and  brain  death                                        
            About two decades ago, Lowensohn tested whether or not the characteristics of the adult heart rate 
reflected the condition of the central nervous system as they appear to characterise it in the fetus. They found 
that  the normal cyclic changes in heart  rate were reduced in  the presence of severe  brain damage.  HRV 
decreased  rapidly  when  intracranial  pressure  rose,  and   the   rate   of  return  of  variability  reflected  the 
subsequent state of neuronal function, even when intracranial pressure was restored to normal. Thus, it appears 
in this limited setting that HRV may reflect  the functional  state of the central nervous system  17.  Power 
spectral analysis of HRV was later proposed as a tool to diagnose and monitor brain damage 11,14. In 1990s 
Goldstein et al demonstrated a strong negative correlation between HRV (low frequency power) and severity 
of brain injury, survival, and neurologic outcome in paediatric populations 14-16. More recently, Conci et al 
evaluated spontaneous variability of heart rate estimated by pulse interval in 11 patients shortly before and 1 
hour after the onset of brain death. Significant spectral changes occurred after brain death with a general power 
reduction in pulse interval spectra; A significant shift of pulse interval powers toward the lower frequencies 
occurred  after  brain  death  together  with  a  general  power  reduction  in  pulse  interval  spectra  parameters 
describing  spontaneous  HRV underwent  marked  changes  with  the  onset  of  brain  death.  Most  likely,  the 
changes reflect the cessation of activity of the cardiovascular brain stem centres. Hence, Conci et al suggested 
that spectral analysis of HRV, along with the analysis of baroreflex sensitivity and blood pressure variability, 
may  be  used  as  a  complementary  tool  to  confirm the  diagnosis  of  brain  stem  death  13.  Rapenne  et  al 
prospectively investigated whether HRV analysis could predict outcome in patients with severe head injury 
(n=20). They compared HRV (on Day 1) in patients who progressed to brain death to HRV in survivors; as 
well as HRV in survivors with good recovery (Glasgow Coma Scale >or= 10) to HRV in those with worsened 
neurologic state (Glasgow Coma Scale < 10). At day 1, in the 6 patients who had progressed to brain death, 
global HRV and parasympathetic tone were significantly higher, while during the awaking period, global HRV 
and the parasympathetic tone were significantly lower in the worsened neurologic state group. These findings 
suggest that HRV may be a helpful predictor of imminent brain death and a useful adjunct for predicting the 
outcome of patients with severe head injury 43. Baillard et al 6 further evaluated HRV continuously during the 
time of brain death. They showed that an improved method of HRV analysis immediately identified the loss in 
the spectral power of heart rate occurring during transition to brain death. This approach may be used to 
confirm the  cessation of  brainstem function in  clinical  practice.                                      
Acute  brainstem  stroke                                        
            Meglic et al  assessed HRV by power spectra  analysis in 14 patients with acute brainstem stroke. 
Transient dysfunction of autonomic nervous system was found in patients with acute medullary stroke (n=6) in 
contrast to those with non-medullary (n=8) brainstem stroke 44. However, the size of the study population may 
limit  the  value  of  this  report.                                 
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Guillain-Barre  syndrome                                              
            Flachenecker et al conducted serial studies in patients with Guillain-Barre syndrome and found that the 
sympathovagal balance shifted to sympathetic predominance at the height of the disease  45-47. The authors 
concluded that the 24-hour heart rate power spectrum may yield sensitive and specific markers for assessing 
the risk of impending and potentially life-threatening arrhythmias in patients with Guillain-Barre syndrome. 
Risk  assessment  in  renal  failure                                        
            Cardiac autonomic dysfunction is associated with mortality in patients with end-stage renal disease. 
Cashion et al evaluated the value of HRV analysis in 278 patients with end-stage renal disease to identify those 
at high risk of sudden cardiac death. They showed that end-stage renal disease patients, particularly diabetics, 
had a compromised autonomic function. Although they suggest that 24-hour time domain measure of the HRV 
held the promise of identifying patients at increased risk of death, this study contained only 5 patients with 
sudden cardiac  death  48.  In  patients  with  end-stage  renal  disease  who  underwent  chronic  haemodialysis, 
uraemia causes similar but reversible changes in HRV in non-diabetic haemodialysis patients 49.
Evaluation  outcomes  in  sepsis  and  shock                                   
            Godin et al prospectively studied the relation between human endotoxemia to loss of the physiologic 
beat-to-beat variability of heart rate. They found that endotoxin administration was associated with loss of the 
variability by all measures of HRV in healthy volunteers  50. Later findings obtained from patients were in 
agreement with the experimental results from healthy subjects. Korach et al found that sepsis was strongly 
associated with a low to high frequency ration <1.50, with an odds ratio of 3.63 (95% confidence interval 1.47 
- 9.01, p=0.005) in a study of 41 patients. The authors suggested that a low to high frequency ratio <1.0 may 
be a diagnostic test for sepsis 10. However, the reproducibility of the low to high frequency ratio is a reason for 
concern  and  these  findings  need  to  be  confirmed  by  studying  larger  populations.
            It was hypothesised that septic shock resulted in an uncoupling of organ system interconnectivity and 
that  the  uncoupling  phenomenon could  be  quantified  as  a  loss  in  HRV  51.  Goldstein  et  al  showed  that 
endotoxin caused a loss in HRV in rabbit models of sepsis. They speculated that a concomitant decrease in 
low-frequency HR power as mean arterial pressure decreases may be an early marker for impending shock 52. 
Ellenby et al evaluated uncoupling and recoupling phenomenon in 7 children with septic shock by observing 
serial changes in HRV. Heart rate time series were analysed at 6-hour intervals of during hospitalisation at 
paediatric intensive care unit. Six of 7 patients showed an increase over time in low-frequency component of 
HRV and the low to high-frequency ratio, whereas high-frequency component of HRV decreased. The study 
also compared the change in mean heart rate, heart rate standard deviation, and power spectral HRV values 
during the first 24-hour of paediatric intensive care unit hospitalisation versus the remainder of the stay. In the 
later hospitalisation, low-frequency component of HRV and the low-/high-frequency ratio increased, whereas 
high-frequency component of HRV decreased over the course of the illness. This report showed the potential 
value of monitoring HRV in paediatric patients with septic shock51. These results were in agreement with 
early studies showing evidence of decomplexification in experimental models of sepsis52 and with recent 
clinical  studies10,53.                                  
Fetal  and  neonatal  monitoring                                      
            As early as in 1965, Hon and Lee noted that fetal distress was preceded by alterations in the beat-to-
beat  intervals before any appreciable changes occurred in heart  rate  itself  54.  More recently,  Griffin et al 
prospectively  evaluated  the  heart  rate  characteristics,  which  described  the  symmetry  of  histogram of  RR 
intervals, in 89 infants at risk for sepsis and sepsis-like illness. They found that new-born infants who had 
abrupt clinical deterioration as a result of sepsis and sepsis-like illness, had abnormal heart rate characteristics. 
Heart rate characteristics and the Score for Neonatal Acute Physiology worsened over 24 hours before the 
clinical suspicion of sepsis. Their findings suggested that HRV analysis might help with an earlier diagnosis 
and more effective therapy  55.  Chung et al performed a fetal HRV analysis in 76 pregnant women. They 
reported that a computerised spectral analysis of fetal HRV was a good predictor of fetal distress by showing a 
negative  predictive  accuracy  for  predicting presumed distress  or  acidemic  distress  of  99%.  However,  the 
positive  predictive  accuracy was only  12%  56.  The  effect  of  maternal  administration of  meperidine  with 
promethazine should be taken into account when monitoring fetal HRV during the active phase of normal 
labour  57.                                            
Other  clinical  potential                                                 
            A number of recent studies showed that altered HRV was found in other patients populations including
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Parkinson disease 58, sleep apnoea 59,60, Chagas' disease 61 etc. Altered HRV was also associated with some 
critical  conditions  such  as  patients  with  cirrhosis  of  the  liver  62,  pregnant  eclampsia  63,  and  tetanus  64. 
However, the clinical use of HRV assessment in these areas has not been systematically explored. 
Future  prospects                                          
            The expansion of heart rate variability analysis has been facilitated by the remarkable development of 
computer sciences and digital signal processing during the last decades. The prognostic value of time and 
geometric parameters of HRV has been consistently confirmed. It seems encouraging that HRV analysis may 
provide additional diagnostic and prognostic information within the context of multiple confounding factors, 
which are associated with various pathophysiologic conditions. It has been known that both linear and non-
linear  components of HRV may be significantly altered in critically  ill  patients  65.  The newer non-linear 
methods might  predict  risk more precisely in cardiac or other critically ill  patients2,9,66,  however,  further 
evaluations are needed. This non-invasive methodology is of substantial utility to evaluate autonomic control 
mechanisms and to identify patients with an increased mortality in spite of an incomplete understanding of the 
physiological significance of HRV parameters. Further prospective studies are required to define limits of 
HRV indices for the use in managing individual patient under various clinical settings.                                    
Conclusions
            HRV analysis is a recognised tool for the estimation of cardiac autonomic modulations. Reduced HRV 
is a powerful and independent predictor of an adverse prognosis in patients with cardiac disease. It has a 
potential to become a non-invasive diagnostic and prognostic index in clinical practice, particularly in patients 
with  post  myocardial  infarction  and  diabetic  neuropathy.  Although  assessment  of  HRV  in  other  clinical 
settings  seems  to  be  helpful  and  promising,  substantial  number  of  further  prospective  studies  in  larger 
population are needed to evaluate the validity of HRV in general medicine.                                     
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